Table 2.
Variable | No. (%) |
---|---|
Sex (N = 15 050) | |
Male | 4322 (28.7) |
Female | 10 728 (71.3) |
Age, y | |
0–14 | 451 (3.0) |
15–24 | 1749 (11.6) |
25–64 | 12 692 (84.3) |
≥65 | 158 (1.1) |
Age, y, median (IQR) | 34 (28–42) |
Educationa (n = 12 254) | |
None | 1045 (8.5) |
Primary | 3289 (26.8) |
Secondary | 7922 (64.6) |
Marital statusa (n = 14 216) | |
Never married | 4190 (29.5) |
Married | 8644 (60.8) |
Previously married | 1382 (9.7) |
Occupationa (n = 13 082) | |
Employed | 4324 (33.1) |
Unemployed | 7822 (59.8) |
Student | 936 (7.2) |
WHO clinical stagea (n = 14 800) | |
I | 5440 (36.8) |
II | 4342 (29.3) |
III | 4758 (32.2) |
IV | 260 (1.8) |
Regimenb (n = 14 695) | |
HIV integrase inhibitors | 14 656 (99.7) |
Protease inhibitors | 32 (0.2) |
NNRTIs | 7 (0.1) |
Time undergoing ART, y | |
1.5–3 | 3487 (23.2) |
4–5 | 4666 (31.0) |
6–10 | 4593 (30.5) |
>10 | 2304 (15.3) |
Enrollment in DSD | |
Yes | 13 636 (90.6) |
No | 1414 (9.4) |
ART initiation settinga (n = 14 976) | |
Facility | 562 (3.8) |
Community | 14 414 (96.3) |
Abbreviations: ART, antiretroviral therapy; DSD, differentiated service delivery; NNRTI, nonnucleoside reverse transcriptase inhibitor; WHO, World Health Organization.
aWith missing data.
bAnalyzed for first-line ART only.